Dinaciclib synergizes with BH3 mimetics targeting BCL-2 and BCL-X<sub>L</sub> in multiple myeloma cell lines partially dependent on MCL-1 and in plasma cells from patients.

Mol Oncol · 2023 · PMC10701777 · PMID 37704591

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Nevertheless, FISH− samples tend to be more sensitive to S63845 than altered ones, but this tendency did not reach statistical significance due to the wide range of responses.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.